CompletedNCT00961454
Light-based treatment and brain blood flow in depression
About this title
Read the official source — NCT00961454Device studyAges 18–60United States
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
- Listed locations
- BostonSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateJanuary 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Device
- Intervention type
- Device
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT00961454
- Official title
Show the full official title
A Pilot Study to Evaluate the Ability of Photobiomodulation to Alter Cerebral Blood Flow in the Frontal Poles and to Affect the Emotional Status of Patients With Major Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
